Skip to content
IPO GMP
Mainboardupcoming

Integris Medtech IPO GMP

Integris Medtech IPO is a Mainboard issue. It opens on 27 Nov 2026 and closes on 1 Dec 2026. Listing is expected on 4 Dec 2026.

GMP today
No GMP yet
Est. listing price
–
Price band
–
Subscription
Opens 27 Nov

GMP trend

No GMP has been recorded for this IPO yet.

IPO details

Min. investment
Not published
Fresh issue
₹600 Cr
Offer for sale
1.08 Cr shares
Face value
₹1 per share
Sector
Medical Equipment & Supplies
QIB quota
Not less than 75% of the Offer
NII quota
Not more than 15% of the Offer
Retail quota
Not more than 10% of the Offer
Promoter holding
83.24%
Listing at
NSE, BSE
Lead managers
ICICI Securities Ltd., Citigroup Global Markets India Pvt.Ltd., IIFL Capital Services Ltd., Axial Capital Pvt.Ltd.

Timeline

Anchor bidding
26 Nov 2026
Open date
27 Nov 2026
Close date
1 Dec 2026
Allotment
2 Dec 2026
Refunds start
3 Dec 2026
Shares in demat
3 Dec 2026
Listing date
4 Dec 2026
Anchor lock-in ends (50%)
1 Jan 2027
Anchor lock-in ends (rest)
2 Mar 2027
Add dates to calendar

Subscription status

Bidding opens 27 Nov 2026.

Financials (₹ Cr)

Period ended30-Jun-2531-Mar-2531-Mar-2431-Mar-23
Assets4,019.623,641.342,989.22,553.87
Revenue508.931,959.581,582.261,369.66
Profit After Tax267.5770.684.8840.54
Net Worth3,889.992,752.522,681.022,629.52
Reserves & Surplus2,299.841,150.741,135.711,073.12
Total Borrowing793.421,729.46813.1556.54

Objects of the issue

  • Repayment/ prepayment, in full or in part, of certain outstanding borrowings, interest accrued and prepayment penalties, as applicable, availed by:
  • The wholly-owned Subsidiaries, namely, Translumina Therapeutics Pvt.Ltd. (Translumina Therapeutics), Transhealth Pvt.Ltd. (Transhealth) ) and HaleMed Medical Pvt.Ltd.
  • The step-down Subsidiaries, namely, CPC Diagnostics Pvt.Ltd., Chemopharm Sdn. Bhd., Chemoscience Pte Ltd., Lifeline Diagnostics Supplies Inc., Hausen Bernstein Co. Ltd, Medigene Sdn. Bhd., Research Instruments Sdn Bhd and Research Instruments Pte. Ltd.
  • General Corporate Purposes

Promoters

Evercure Holdings Pte.Ltd., Medicore Holdings Pte.Ltd., Gurmit Singh Chugh, Punita Sharma

About Integris Medtech

Founded in 2008, Integris Medtech Ltd is an India based international company which manufactures and provides global medical products and laboratory solutions for medical products and laboratory solutions. The company designs, manufactures, markets, and distributes an extensive range of medical devices and solutions that include cardiovascular devices, clinical diagnostics, and scientific laboratory solutions. Integris Medtech has operations located in India, Germany, and the Netherlands. It sells its product line in more than 65 international markets in India, Europe, and Southeast Asia. The company's customer segment comprises of more than 9,500 laboratories and 2,000 hospitals and cathlabs and a portfolio of over 22,000 SKUs with more than 200 brands of laboratory and cardiovascular segments. The core divisions of the company's operations include: Cardiovascular Devices – including drug eluting stents, drug coated balloons, advanced coronary interventions and vascular access. Laboratory Solutions – including clinical, research, and industrial laboratory devices, reagents, and consumables, as well as instrumentation service such as installation, maintenance and calibration via its BioCal product line. The firm caters to laboratories and hospital facilities situated in India, Singapore, Thailand, Malaysia, and the Philippines, serving the government sector as well as private sector entities. European operations of the company deal mostly with products used in cardiology, which include its own product range, namely the Chrome and Protégé series of instruments. By June 30, 2025, Integris Medtech boasted 1,879 employees, which were sales, service, and application experts. Moreover, more than 15,000 patients were supported by the company through more than 100 clinical trial sites in various parts of the world.

Company contact

Name
Integris Medtech
Address
1 st Floor, Metro Tower LSC, M.O.R Land, New Rajinder Nagar, North Delhi, New Delhi, 110060

Registrar contact

Name
Kfin Technologies Ltd.

Integris Medtech IPO: FAQs

2 questions

01When is the Integris Medtech IPO allotment date?

The basis of allotment is expected on 2 Dec 2026. Kfin Technologies Ltd. is the registrar, where you can check allotment status with your PAN or application number.

02When will Integris Medtech shares list?

The tentative listing date is 4 Dec 2026 on NSE and BSE.